Leerink Swann Research Analysts Lift Earnings Estimates for Novartis AG


Investment analysts at Leerink Swann boosted their FY2020 earnings per share estimates for Novartis AG in a research report issued to clients and investors on Thursday. Leerink Swann analyst S. Fernandez now forecasts that the company will post earnings per share of $5.69 for the year, up from their prior forecast of $5.68.



from Biotech News